Company intelligence / Profile preview

Sente Labs

Carlsbad, California, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Sente is a medical-grade skincare company that utilizes biotechnology to address skin health and aging. The company is best known for its proprietary Heparan Sulfate Analog (HSA) technology, which mimics the body's natural heparan sulfate to promote skin repair and reduce inflammation. Sente's products are primarily sold through dermatologists and plastic surgeons, targeting conditions such as chronic redness, photoaging, and dehydration. In 2022, Sente was acquired by Galderma, integrating its science-based formulations into Galderma's global dermatology portfolio.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Partnerships

Galderma

Beyond the preview

Go deeper on Sente Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sente Labs.

Explore the full profile